Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

This publication has 296 references indexed in Scilit:

• DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1
  Transplantation, 2000
• Diabetic Dyslipidaemia
  Drugs, 2000
• Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers
  The Journal of Clinical Pharmacology, 2000
• Cardiovascular morbidity and risk factors in renal transplant patients
  Nephrology Dialysis Transplantation, 1999
• Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy
  The Journal of Pediatrics, 1997
• Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial
  The Journal of Pediatrics, 1997
• Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure
  American Journal of Kidney Diseases, 1997
• Increased low density lipoprotein oxidation in stable kidney transplant recipients
  Kidney International, 1996
• Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment
  The Journal of Clinical Pharmacology, 1992
• The Effect of Renal Function on the Pharmacokinetics of Gemfibrozil
  The Journal of Clinical Pharmacology, 1987